Titel

Merkliste
1 Ergebnisse

First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in..:

Reck, Martin ; Ciuleanu, Tudor Eliade ; Lee, Jong Seok...
https://eprints.qut.edu.au/227560/1/1_s2.0_S1556086421000411_main.pdf. , 2021

Link: https://eprints.qut.edu.au/227560/

RT Journal
T1 <Title>First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in Advanced NSCLC With 1% or Greater Tumor PD-L1 Expression: Patient-Reported Outcomes From CheckMate 227 Part 1</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftqueensland:oai:eprints.qut.edu.au:227560&Exemplar=1&LAN=DE
				
A1 Reck, Martin
A1 Ciuleanu, Tudor Eliade
A1 Lee, Jong Seok
A1 Schenker, Michael
A1 Audigier-Valette, Clarisse
A1 Zurawski, Bogdan
A1 Linardou, Helena
A1 Otterson, Gregory A
A1 Salman, Pamela
A1 Nishio, Makoto
A1 de la Mora Jimenez, Emmanuel
A1 Lesniewski-Kmak, Krysztof
A1 Albert, István
A1 Ahmed, Samreen
A1 Syrigos, Konstantinos
A1 Penrod, John R
A1 Yuan, Yong
A1 Blum, Steven I
A1 Nathan, Faith E
A1 Sun, Xiaowu
A1 Moreno-Koehler, Alejandro
A1 Taylor, Fiona
A1 O'Byrne, Kenneth John
PB International Association for the Study of Lung Cancer
YR 2021
K1 First-line metastatic non–small cell lung cancer
K1 Ipilimumab
K1 Nivolumab
K1 Patient-reported outcomes
K1 Quality of life
JF https://eprints.qut.edu.au/227560/1/1_s2.0_S1556086421000411_main.pdf
LK http://dx.doi.org/https://eprints.qut.edu.au/227560/
DO https://eprints.qut.edu.au/227560/
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)